Clinical Trials Browser

Interventional × Pharmacogenomic Variants × Other hematologic neoplasm × Clear all

NCT03479268 2026-04-27

Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Prolymphocytic, B-Cell

NCT03557970 2021-12-02

JNJ-40346527 in Treating Participants With Relapsed or Refractory Acute Myeloid Leukemia

Phase 2 Terminated

3 enrolled 10 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute